Furthermore, we detected that high USP9X gene expression correlated with a worse outcome in patients with prostate cancer, although USP9X gene expression was slightly but insignificantly lower in prostate cancer tissues than in normal tissue. This evidence concerns the gene USP9X and Familial prostate cancer.